{"id":71901,"date":"2021-11-17T16:58:31","date_gmt":"2021-11-17T16:58:31","guid":{"rendered":"https:\/\/www.atlasrleye.com\/vitreorretinopatia-familiar-exudativa\/"},"modified":"2025-05-29T02:48:00","modified_gmt":"2025-05-29T02:48:00","slug":"vitreorretinopatia-familiar-exudativa","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/es\/vitreorretinopatia-familiar-exudativa\/","title":{"rendered":"VITREORRETINOPATIA FAMILIAR EXUDATIVA"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=\u00bbENFERMEDADES CONG\u00c9NITAS Y PEDI\u00c1TRICAS DE LA RETINA\u00bb font_container=\u00bbtag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=\u00bbyes\u00bb link=\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Fes%2Fatlas%2F%231635506431806-afc59564-1028|\u00bb][vc_text_separator title=\u00bb\u00bb i_icon_fontawesome=\u00bbfas fa-eye\u00bb i_color=\u00bbcustom\u00bb i_size=\u00bblg\u00bb color=\u00bbcustom\u00bb border_width=\u00bb8″ css=\u00bb.vc_custom_1637080776101{margin-bottom: -5px !important;}\u00bb add_icon=\u00bbtrue\u00bb accent_color=\u00bb#bababa\u00bb i_custom_color=\u00bb#bababa\u00bb][vc_custom_heading source=\u00bbpost_title\u00bb font_container=\u00bbtag:h1|font_size:44px|text_align:center|color:%235f1b52″ use_theme_fonts=\u00bbyes\u00bb]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb3\/4″][vc_column_text css=\u00bb\u00bb]<\/p>\n
\n

La vitreorretinopatia exudativa familiar (FEVR) es una distrofia vitreorretiniana de transmisi\u00f3n autos\u00f3mica dominante. Es m\u00e1s com\u00fan en la primera d\u00e9cada de vida y, aunque las alteraciones sean bilaterales, su desarrollo es asim\u00e9trico.<\/p>\n

La VEVR es caracterizada por alteraciones en la interfase vitreorretiniana y por isquemia perif\u00e9rica de la retina, generalmente en el \u00e1rea temporal.<\/p>\n

Esta enfermedad es diferenciada en tres etapas cl\u00ednicas: en etapa I los pacientes son asintom\u00e1ticos y hay alteraciones en la interfase vitreorretiniana y en las \u00e1reas no vasculares perif\u00e9ricas; la etapa II es proliferativa y exudativa, en la que pueden ser observadas neovascularizacion, proliferaci\u00f3n fibrovascular y exudaci\u00f3n sub y intrarretiniana; en la etapa II la lesi\u00f3n cicatricial provoca desprendimiento de retina traccional y regmat\u00f3geno y pliegues falciformes.<\/p>\n<\/div>\n

[\/vc_column_text][\/vc_column][vc_column width=\u00bb1\/4″][vc_images_carousel images=\u00bb4963,4973,4987,5015,4988,5016″ img_size=\u00bbmedium\u00bb speed=\u00bb2000″ hide_pagination_control=\u00bbyes\u00bb wrap=\u00bbyes\u00bb css=\u00bb.vc_custom_1748485952144{margin-bottom: 10px !important;}\u00bb]

\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>
0<\/div>
Casos Cl\u00ednicos<\/div><\/div><\/div>[\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00bb.vc_custom_1748485968305{margin-bottom: 10px !important;}\u00bb]<\/p>\n

Casos Cl\u00ednicos<\/span><\/strong><\/h1>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb1\/4″][vc_column_text css=\u00bb.vc_custom_1748485981996{margin-bottom: 0px !important;}\u00bb]<\/p>\n

Caso Cl\u00ednico 1<\/a><\/h4>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb4959,4958″ img_size=\u00bb150″ css=\u00bb.vc_custom_1748486010167{margin-bottom: 10px !important;margin-left: -20px !important;}\u00bb][vc_row_inner][vc_column_inner width=\u00bb1\/5″ offset=\u00bbvc_col-xs-1\/5″]

\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

5<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][vc_column_inner width=\u00bb1\/5″ offset=\u00bbvc_col-xs-1\/5″]
\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

40<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][vc_column_inner width=\u00bb1\/5″ offset=\u00bbvc_col-xs-1\/5″]
\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

0<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=\u00bb1\/4″][vc_column_text css=\u00bb.vc_custom_1748486138347{margin-bottom: 0px !important;}\u00bb]<\/p>\n

Caso Cl\u00ednico 2<\/a><\/h4>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb4957,4962″ img_size=\u00bb150″ css=\u00bb.vc_custom_1748486098418{margin-bottom: 10px !important;margin-left: -20px !important;}\u00bb][vc_row_inner][vc_column_inner width=\u00bb1\/5″ offset=\u00bbvc_col-xs-1\/5″]

\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

4<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][vc_column_inner width=\u00bb1\/5″ offset=\u00bbvc_col-xs-1\/5″]
\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

27<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][vc_column_inner width=\u00bb1\/5″ offset=\u00bbvc_col-xs-1\/5″]
\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

0<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=\u00bb1\/4″][vc_column_text css=\u00bb.vc_custom_1748486204996{margin-bottom: 0px !important;}\u00bb]<\/p>\n

Caso Cl\u00ednico 3<\/a><\/h4>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb4961,4960″ img_size=\u00bb150″ css=\u00bb.vc_custom_1748486190197{margin-bottom: 10px !important;margin-left: -20px !important;}\u00bb][vc_row_inner][vc_column_inner width=\u00bb1\/5″ offset=\u00bbvc_col-xs-1\/5″]

\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

7<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][vc_column_inner width=\u00bb1\/5″ offset=\u00bbvc_col-xs-1\/5″]
\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

39<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][vc_column_inner width=\u00bb1\/5″ offset=\u00bbvc_col-xs-1\/5″]
\n
\n\t<\/i>\n<\/div><\/div><\/div><\/div>

0<\/h3><\/div> <\/div> <\/div> [\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=\u00bbENFERMEDADES CONG\u00c9NITAS Y PEDI\u00c1TRICAS DE LA RETINA\u00bb font_container=\u00bbtag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=\u00bbyes\u00bb link=\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Fes%2Fatlas%2F%231635506431806-afc59564-1028|\u00bb][vc_text_separator title=\u00bb\u00bb i_icon_fontawesome=\u00bbfas fa-eye\u00bb i_color=\u00bbcustom\u00bb i_size=\u00bblg\u00bb color=\u00bbcustom\u00bb border_width=\u00bb8″ css=\u00bb.vc_custom_1637080776101{margin-bottom: -5px !important;}\u00bb add_icon=\u00bbtrue\u00bb accent_color=\u00bb#bababa\u00bb i_custom_color=\u00bb#bababa\u00bb][vc_custom_heading source=\u00bbpost_title\u00bb font_container=\u00bbtag:h1|font_size:44px|text_align:center|color:%235f1b52″ use_theme_fonts=\u00bbyes\u00bb][\/vc_column][\/vc_row][vc_row][vc_column width=\u00bb3\/4″][vc_column_text css=\u00bb\u00bb] La vitreorretinopatia exudativa familiar (FEVR) es una distrofia vitreorretiniana de transmisi\u00f3n […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-71901","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages\/71901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/comments?post=71901"}],"version-history":[{"count":9,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages\/71901\/revisions"}],"predecessor-version":[{"id":115592,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages\/71901\/revisions\/115592"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/media?parent=71901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}